Verition Fund Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,600
Closed -$275K 2312
2025
Q4
$275K Buy
+12,600
New +$262K ﹤0.01% 3047
2025
Q3
Sell
-13,714
Closed -$352K 3751
2025
Q2
$352K Buy
13,714
+297
+2% +$8.69K ﹤0.01% 3128
2025
Q1
$491K Sell
13,417
-2,073
-13% -$71.3K ﹤0.01% 2599
2024
Q4
$475K Sell
15,490
-6,709
-30% -$223K ﹤0.01% 2514
2024
Q3
$836K Buy
22,199
+16,773
+309% +$647K ﹤0.01% 2007
2024
Q2
$215K Buy
+5,426
New +$176K ﹤0.01% 2550

Other funds holding ATEX

Verition Fund Management's ATEX Position: Q1 2026 in Review

Verition Fund Management sold out of Anterix (ATEX) in Q1 2026, closing a stake of 12,600 shares — an estimated $275K sold.

Verition Fund Management first reported a position in ATEX in Q2 2024 and held it in 6 quarters. The position peaked at $836K in Q3 2024. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Verition Fund Management reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 12,600 Anterix shares in Q1 2026, an estimated $275K.
  • Verition Fund Management first reported a position in Anterix in Q2 2024 and held it in 6 quarters.
  • Verition Fund Management's Anterix position peaked at $836K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.